Plath Michaela, Sand Matthias, van de Weyer Philipp S, Baierl Kilian, Praetorius Mark, Plinkert Peter K, Baumann Ingo, Zaoui Karim
Universitäts-HNO-Klinik Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland.
GESIS-Leibniz-Institut für Sozialwissenschaften, Mannheim, Deutschland.
HNO. 2022 Jun;70(6):422-435. doi: 10.1007/s00106-021-01114-0. Epub 2021 Oct 14.
The Nijmegen Cochlear Implant Questionnaire (NCIQ) is a disease-specific questionnaire to determine the health-related quality of life (HRQoL) of patients before and after cochlear implantation.
This study aimed to assess the validity and reliability of the German translation of the NCIQ.
A prospective study was performed in 100 postlingually deaf or severely hearing-impaired patients. HRQoL was assessed using the NCIQ, the Abbreviated Profile of Hearing Aid Benefit (APHAB), and the Hearing Participation Scale (HPS) before as well as 3 and 6 months after cochlear implantation. An untreated group of postlingually deaf or severely hearing-impaired patients (n = 54) served as a control. Cronbach's α and test-retest reliability were measured. The content, discrimination, and agreement validity were tested. The evaluation of construct validity was based on recently published data. Sensitivity and receiver operating curve (ROC) analysis, including consideration of the area under the curve (AUC), were used as quality criteria.
The test-retest analysis showed stable NCIQ values 3 and 6 months postoperatively. The Cronbach's α values indicated good internal consistency. The NCIQ validly discriminated between treated and untreated patient groups. There were statistically significant albeit weak correlations between the NCIQ and the APHAB (r = -0.22; p = 0.04) and the HPS (r = 0.30; p = 0.01). Sensitivity and ROC analyses showed good measurement quality of the German-speaking NCIQ.
The German translation of the NCIQ reliably and validly measures HRQoL before and after cochlear implantation and can be used for clinical monitoring after treatment with cochlear implants.
奈梅亨人工耳蜗植入问卷（NCIQ）是一份针对特定疾病的问卷，用于确定人工耳蜗植入患者术前和术后与健康相关的生活质量（HRQoL）。
本研究旨在评估NCIQ德文版的有效性和可靠性。
对100名语后聋或重度听力受损患者进行了一项前瞻性研究。在人工耳蜗植入前以及植入后3个月和6个月，使用NCIQ、助听器受益简表（APHAB）和听力参与量表（HPS）评估HRQoL。一组未经治疗的语后聋或重度听力受损患者（n = 54）作为对照。测量了Cronbach's α系数和重测信度。测试了内容效度、区分效度和一致性效度。结构效度的评估基于最近发表的数据。使用敏感性和受试者工作特征曲线（ROC）分析，包括曲线下面积（AUC）的考量，作为质量标准。
重测分析显示术后3个月和6个月NCIQ值稳定。Cronbach's α系数表明具有良好的内部一致性。NCIQ能够有效地区分治疗组和未治疗组患者。NCIQ与APHAB（r = -0.22；p = 0.04）和HPS（r = 0.30；p = 0.01）之间存在虽弱但具有统计学意义的相关性。敏感性和ROC分析显示德语版NCIQ具有良好的测量质量。
NCIQ德文版能够可靠且有效地测量人工耳蜗植入术前和术后的HRQoL，可用于人工耳蜗植入治疗后的临床监测。
